Topics
CNS Tumors | Classification | Overview
Home > Publications > Topics > CNS Tumors > Classification > Overview
Capper D, Stichel D, Sahm F, Jones DTW, Schrimpf D, Sill M, Schmid
S, Hovestadt V, Reuss DE, Koelsche C, Reinhardt A, Wefers AK,
Huang K, Sievers P, Ebrahimi A, Schöler A, Teichmann D, Koch
A, Hänggi D, Unterberg A, Platten M, Wick W, Witt O, Milde T,
Korshunov A, Pfister SM, von Deimling A.
Practical
implementation of DNA methylation and copy-number-based CNS tumor
diagnostics: the Heidelberg experience.
Acta
Neuropathol. 2018 Jul 2;136(2):181-210. doi:
10.1007/s00401-018-1879-y. PMID:
29967940. Observational study. ˍ
Antonelli M, Poliani PL.
Adult type
diffuse gliomas in the new 2021 WHO Classification.
Pathologica.
2022 Dec 19;114(6):397-409. doi:
10.32074/1591-951X-823. PMID:
36534419. Review. ˍ
Barbareschi M, Gessi M, Giangaspero F.
Introduction.
Pathologica.
2022 Dec 19;114(6):395-396. doi:
10.32074/1591-951X-839. PMID:
36534418. Editorial. ˍ
Barresi V, Gianno F, Marucci G.
Newly
recognised Tumour Types in Glioneuronal tumours according to the
5th edition of the CNS WHO Classification.
Pathologica.
2022 Dec;114(6):447-454. doi:
10.32074/1591-951X-819. PMID:
36534423. Review. ˍ
Bertero L, Ricci AA, Tampieri C, Cassoni P, Modena P.
Ependymomas.
Pathologica.
2022 Dec 19;114(6):436-446. doi:
10.32074/1591-951X-817. PMID:
36534422. Review. ˍ
Fabbri VP, Caporalini C, Asioli S, Buccoliero A.
Paediatric-type
diffuse low-grade gliomas: a clinically and biologically distinct
group of tumours with a favourable outcome.
Pathologica.
2022 Dec 19;114(6):410-421. doi:
10.32074/1591-951X-828. PMID:
36534420. Review. ˍ
Gianno
F, Giovannoni I, Cafferata B, Diomedi-Camassei F, Minasi S,
Barresi S, Buttarelli FR, Alesi V, Cardoni A, Antonelli M,
Puggioni C, Colafati GS, Carai A, Vinci M, Mastronuzzi A, Miele E,
Alaggio R, Giangaspero F, Rossi S.
Paediatric-type
diffuse high-grade gliomas in the 5th CNS WHO Classification.
Pathologica.
2022 Dec 19;114(6):422-435. doi:
10.32074/1591-951X-830. PMID:
36534421. Review. ˍ
Pizzimenti C, Gianno F, Gessi M.
Expanding
the spectrum of "mesenchymal" tumors of the central
nervous system.
Pathologica.
2022 Dec 19;114(6):455-464. doi:
10.32074/1591-951X-826. PMID:
36534424.
Review. ˍ
Drexler R, Brembach F, Sauvigny J,
Ricklefs FL, Eckhardt A, Bode H, Gempt J, Lamszus K, Westphal M,
Schüller U, Mohme M.
Unclassifiable
CNS tumors in DNA methylation-based classification: clinical
challenges and prognostic impact.
Acta
Neuropathol Commun.
2024 Jan 16;12(1):9. doi:
10.1186/s40478-024-01728-9. PMID:
38229158. Observational study. ˍ
RELATED
ARTICLE
Capper D, Stichel D, Sahm F, Jones DTW, Schrimpf D,
Sill M, Schmid S, Hovestadt V, Reuss DE, Koelsche C, Reinhardt A,
Wefers AK, Huang K, Sievers P, Ebrahimi A, Schöler A,
Teichmann D, Koch A, Hänggi D, Unterberg A, Platten M, Wick
W, Witt O, Milde T, Korshunov A, Pfister SM, von Deimling A.
Practical
implementation
of DNA methylation and copy-number-based CNS tumor diagnostics:
the
Heidelberg experience.
Acta
Neuropathol.
2018 Jul 2;136(2):181-210. doi:
10.1007/s00401-018-1879-y. PMID:
29967940. Observational study. ˍ